Recherche
Résultats 1-10 de 20
-
Irrecist and irecist: the devil is in the details
Annals of oncology . official journal of the European Society for Medical Oncology, 01-07-2017, 28, 1676-1678Article dans une revue scientifique -
Incidence and risk factors for ifosfamide-related encephalopathy in sarcoma patients
Bulletin du cancer, 01-03-2017, 104, 208-212Article dans une revue scientifique -
A randomized, double-blind, placebo-controlled phase ii study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy
Annals of oncology . official journal of the European Society for Medical Oncology, 01-11-2017, 28, 2741-2746Article dans une revue scientifique -
How to emerge from the conservatism in clinical research methodology?
Current opinion in oncology, 01-09-2017, 29, 400-404Article dans une revue scientifique -
Which recent results in oncology and hematology will have an impact on our practices? the point of vue of bulletin du cancer editorial board
Bulletin du cancer, 01-01-2017, 104, 6-19Article dans une revue scientifique -
Regosarc: regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-a quality-adjusted time without symptoms of progression or toxicity analysis
Cancer, 15-06-2017, 123, 2294-2302Article dans une revue scientifiquetexte intégral -
An update on the management of sporadic desmoid-type fibromatosis: a european consensus initiative between sarcoma patients euronet (spaen) and european organization for research and treatment of cancer (eortc)/soft tissue and bone sarcoma group (stbsg)
Annals of oncology . official journal of the European Society for Medical Oncology, 01-10-2017, 28, 2399-2408Article dans une revue scientifiquetexte intégral -
First-line management of metastatic castrate-resistant prostate cancer patients: audit of real-life practices
Bulletin du cancer, 01-06-2017, 104, 552-558Article dans une revue scientifique -
Targeting angiogenesis in advanced soft tissue sarcoma: tivozanib - hype or me-too?
Annals of oncology . official journal of the European Society for Medical Oncology, 01-01-2017, 28, 13-15Article dans une revue scientifique -
Lessons from three phase iii trials assessing neoadjuvant treatment in sarcoma patients
Annals of oncology . official journal of the European Society for Medical Oncology, 01-11-2017, 28, 2891-2893Article dans une revue scientifique